Treatment with stiripentol in a patient with primary hyperoxaluria type 1: lesson for the clinical nephrologist

J Nephrol. 2022 Apr;35(3):1049-1051. doi: 10.1007/s40620-021-01116-9. Epub 2021 Jul 20.

Authors

Priscillia Violier¹, Olivia Boyer², Romain Berthaud³, Guillaume Dorval³

Affiliations

¹ Pediatric Nephrology Unit, University Hospital of Lille, Lille, France.
² Néphrologie Pédiatrique et Institut Imagine, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015, Paris, France. [email protected].
³ Néphrologie Pédiatrique et Institut Imagine, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015, Paris, France.

PMID: 34283403
DOI: 10.1007/s40620-021-01116-9

No abstract available

Keywords: Case report; Primary hyperoxaluria type 1; Stiripentol; Supportive care.

MeSH terms

Anticonvulsants / therapeutic use
Dioxolanes* / therapeutic use
Humans
Hyperoxaluria, Primary* / complications
Hyperoxaluria, Primary* / diagnosis
Hyperoxaluria, Primary* / drug therapy
Nephrologists

Substances

Anticonvulsants
Dioxolanes
stiripentol

Supplementary concepts

Primary hyperoxaluria type 1